Rosalía Valero

992 total citations
41 papers, 483 citations indexed

About

Rosalía Valero is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Rosalía Valero has authored 41 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Transplantation, 19 papers in Surgery and 6 papers in Nephrology. Recurrent topics in Rosalía Valero's work include Renal Transplantation Outcomes and Treatments (24 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Transplantation: Methods and Outcomes (5 papers). Rosalía Valero is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Organ Transplantation Techniques and Outcomes (14 papers) and Transplantation: Methods and Outcomes (5 papers). Rosalía Valero collaborates with scholars based in Spain, United States and France. Rosalía Valero's co-authors include Juan Carlos Ruiz, Emilio Rodrigo, Gema Fernández‐Fresnedo, Celestino Piñera, R. Palomar, Ana Sánchez‐Fructuoso, Manuel Arias, J. González-Cotorruelo, C. Gómez-Alamillo and Natalia Calvo and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Rosalía Valero

38 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosalía Valero Spain 12 260 158 91 87 73 41 483
Evaldo Favi Italy 13 242 0.9× 181 1.1× 100 1.1× 58 0.7× 123 1.7× 72 571
Clifford D. Miles United States 13 309 1.2× 249 1.6× 79 0.9× 135 1.6× 33 0.5× 30 558
Bénédicte Janbon France 15 266 1.0× 163 1.0× 87 1.0× 111 1.3× 68 0.9× 39 518
Abanti Chaudhuri United States 12 164 0.6× 122 0.8× 179 2.0× 96 1.1× 49 0.7× 35 501
Tracey Ying Australia 9 235 0.9× 156 1.0× 107 1.2× 43 0.5× 71 1.0× 22 406
P.F. Westeel France 12 456 1.8× 132 0.8× 143 1.6× 125 1.4× 78 1.1× 25 689
J. Thielke United States 13 430 1.7× 293 1.9× 84 0.9× 80 0.9× 103 1.4× 25 610
M.R. Laftavi United States 14 370 1.4× 268 1.7× 97 1.1× 62 0.7× 79 1.1× 48 530
Inge B. Brekke Norway 12 316 1.2× 302 1.9× 55 0.6× 50 0.6× 88 1.2× 22 555
Noritoshi Amada Japan 12 146 0.6× 129 0.8× 30 0.3× 57 0.7× 55 0.8× 40 326

Countries citing papers authored by Rosalía Valero

Since Specialization
Citations

This map shows the geographic impact of Rosalía Valero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalía Valero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalía Valero more than expected).

Fields of papers citing papers by Rosalía Valero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalía Valero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalía Valero. The network helps show where Rosalía Valero may publish in the future.

Co-authorship network of co-authors of Rosalía Valero

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalía Valero. A scholar is included among the top collaborators of Rosalía Valero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalía Valero. Rosalía Valero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irure‐Ventura, Juan, María O. Valentín, Lara Belmar, et al.. (2024). Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs. One single-center experience. Human Immunology. 85(3). 110806–110806. 2 indexed citations
2.
3.
Ocejo‐Vinyals, J. Gonzalo, et al.. (2023). Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load. Biomedicines. 11(10). 2741–2741. 9 indexed citations
4.
Carro, Clara García, et al.. (2022). FC 116: SGLT2 Inhibitors in Kidney Transplantation: A Multicenter Study. Nephrology Dialysis Transplantation. 37(Supplement_3). 2 indexed citations
5.
Garcı́a-Unzueta, Maria Teresa, et al.. (2022). Growth Differentiation Factor 15 Is Superior to Troponin I in the Evaluation of Kidney Transplant Candidates. American Journal of Nephrology. 53(2-3). 118–128. 3 indexed citations
6.
Miñambres, Eduardo, Javier Gómez‐Román, Lara Belmar, et al.. (2022). Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion Does Not Increase Graft Fibrosis in the First Year Posttransplant Surveillance Biopsy. Experimental and Clinical Transplantation. 20(12). 1069–1075. 3 indexed citations
7.
Miñambres, Eduardo, Emilio Rodrigo, Borja Suberviola, et al.. (2020). Strict selection criteria in uncontrolled donation after circulatory death provide excellent long‐term kidney graft survival. Clinical Transplantation. 34(9). e14010–e14010. 9 indexed citations
8.
Valero, Rosalía, et al.. (2020). Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits Allosensitization. Biomedicines. 8(4). 72–72. 7 indexed citations
9.
Irure‐Ventura, Juan, David San Segundo, Emilio Rodrigo, et al.. (2020). High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection. International Journal of Molecular Sciences. 21(3). 779–779. 11 indexed citations
10.
Valero, Rosalía, et al.. (2018). Variability of the Mammalian Target of Rapamycin Inhibitors Is Correlated With Long-Term Renal Graft Survival. Transplantation Proceedings. 51(2). 341–343. 2 indexed citations
11.
Valero, Rosalía, et al.. (2018). Effect of Cold Ischemia Time on Kidney Graft Function and Survival: Differences Between Paired Kidney Transplants From the Same Donor. Transplantation Proceedings. 51(2). 321–323. 5 indexed citations
12.
Miñambres, Eduardo, et al.. (2017). Excellent Results from Controlled Donation after Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion. Transplantation. 101. S37–S37. 1 indexed citations
13.
Sánchez‐Fructuoso, Ana, M. L. Maestro, Natalia Calvo, et al.. (2012). Role of Fibroblast Growth Factor 23 (FGF23) in the Metabolism of Phosphorus and Calcium Immediately After Kidney Transplantation. Transplantation Proceedings. 44(9). 2551–2554. 17 indexed citations
14.
Flores, Isabel, et al.. (2012). Anemia in Kidney Transplants Without Erythropoietic Agents: Levels of Erythropoietin and Iron Parameters. Transplantation Proceedings. 44(9). 2590–2592. 10 indexed citations
15.
Delgado, José Luis Carreras, et al.. (2010). Candiduria in Renal Transplant Recipients: Incidence, Clinical Repercussion, and Treatment Indication. Transplantation Proceedings. 42(8). 2944–2946. 24 indexed citations
16.
Sánchez‐Fructuoso, Ana, et al.. (2010). Changes in Magnesium and Potassium Homeostasis after Conversion from a Calcineurin Inhibitor Regimen to an mTOR Inhibitor–Based Regimen. Transplantation Proceedings. 42(8). 3047–3049. 10 indexed citations
17.
Sánchez‐Fructuoso, Ana, et al.. (2010). De Novo Anti-HLA Antibodies in Renal Allograft Recipients: A Cross-Section Study. Transplantation Proceedings. 42(8). 2874–2876. 10 indexed citations
18.
Fernández‐Fresnedo, Gema, Angel de Francisco, Juan Carlos Ruiz, et al.. (2006). Relevance of Chronic Kidney Disease Classification (K/DOQI) in Renal Transplant Patients. Transplantation Proceedings. 38(8). 2402–2403. 13 indexed citations
19.
Fernández‐Fresnedo, Gema, Emilio Rodrigo, Rosalía Valero, & Manuel Arias. (2006). Traditional cardiovascular risk factors as clinical markers after kidney transplantation. Transplantation Reviews. 20(2). 88–94. 8 indexed citations
20.
Rodrigo, Emilio, Gema Fernández‐Fresnedo, Rosalía Valero, et al.. (2006). New-Onset Diabetes after Kidney Transplantation. Journal of the American Society of Nephrology. 17(12_suppl_3). S291–S295. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evaldo Favi Breakdown of academic impact, for papers by Clifford D. Miles Breakdown of academic impact, for papers by Bénédicte Janbon Breakdown of academic impact, for papers by Abanti Chaudhuri Breakdown of academic impact, for papers by Tracey Ying Breakdown of academic impact, for papers by P.F. Westeel Breakdown of academic impact, for papers by J. Thielke Breakdown of academic impact, for papers by M.R. Laftavi Breakdown of academic impact, for papers by Inge B. Brekke Breakdown of academic impact, for papers by Noritoshi Amada
Rankless by CCL
2026